RxDoctor Payments Data

Usman Latif, MD

Pain Medicine · Kansas City, KSNPI 1750443313

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $480,471 of the $733,714 with a category attached, or 65.5%. 19 manufacturers reported payments, led by Nevro Corp. at 32.4% of the total. Among pain medicine clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$733,714in general payments, 2019–2025

Across 917 payments — averaging $800.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$238K
  • Nalu Medical, Inc.$167K
  • Spinal Simplicity, LLC$81K
  • SPR Therapeutics, Inc$80K
  • Globus Medical$56K
  • Saluda Medical Americas, Inc.$46K
  • plus $66K from 13 others
$71,437in research payments, 2019–2025

Across 19 payments — averaging $3759.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Spinal Simplicity, LLC$37K
  • MML US, Inc.$34K
$2,466in ownership & investment interests, 2019–2025

Across 1 payment — averaging $2466.00 each. An ownership or investment interest held by the physician or an immediate family member.

  • Spinal Simplicity, LLC$2K

What the payments were for

  • Consulting fees$480,47165%
  • Speaking & faculty fees$123,81817%
  • Travel & lodging$101,11414%
  • Food & beverage$28,3134%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$733,714 in reported general payments places this provider in the 95th percentile of 64 pain medicine providers in Kansas.

See all pain medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$244,668
Medicare patients
438
Services billed
2,292

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tizanidine Hcl617$6,209
Gabapentin261$5,906
Lidocaine45$3,739
Methocarbamol150$2,854
Pregabalin174$2,746
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen18$834
Nortriptyline Hcl58$693
Duloxetine Hcl37$563
Cyclobenzaprine Hcl54$530
Celecoxib18$436
Ibuprofen16$220
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen24$189
Cephalexin31$145
Meloxicam39$72
Diazepam12$14

Paid to pharmacies, not to this prescriber.

Other pain medicine in Kansas City

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →